机构：[1]Endocrinology, Southeast University Zhongda Hospital, Nanjing,[2]Endocrinology, Chongqing MU Affiliated No. 1 Hospital, Chongqing,[3]Endocrinology, Peking University People’s Hospital, Beijing,[4]Endocrinology, The First Affiliated Hospital of Zhengzhou University, China,[5]Diabetes Care, BD, Franklin Lakes, USA,[6]BD and Company, Beijing, China.
第一作者机构：[1]Endocrinology, Southeast University Zhongda Hospital, Nanjing,
推荐引用方式(GB/T 7714)：
Sun Z.,Li Q.,Ji L.,et al.Lipohypertrophy: prevalence, risk factors, clinical characteristics, and economic burden of insulin-requiring patients in China[J].DIABETOLOGIA.2015,58:S438-S439.
APA：
Sun, Z.,Li, Q.,Ji, L.,Qin, G.,Hirsch, L....&Chandran, A..(2015).Lipohypertrophy: prevalence, risk factors, clinical characteristics, and economic burden of insulin-requiring patients in China.DIABETOLOGIA,58,
MLA：
Sun, Z.,et al."Lipohypertrophy: prevalence, risk factors, clinical characteristics, and economic burden of insulin-requiring patients in China".DIABETOLOGIA 58.(2015):S438-S439
医学